Rallybio to Effect 1 for 8 Reverse Stock Split to Regain Nasdaq Compliance

Rallybio to implement 1 for 8 reverse stock split to regain Nasdaq compliance. The move aims to meet the minimum price requirement for continued listing on Nasdaq and support future business needs. The company received a Nasdaq warning in February 2025 after its stock traded below $1.00 for 30 consecutive business days. No fractional shares will be issued in connection with the reverse split, and stockholders will receive a cash payment in lieu of fractional shares. Rallybio's pipeline candidates address medical needs in complement dysregulation and haematology.